Dyne Therapeutics, Inc. - stock earnings
DYN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -66.6 million USD | 3.8 million USD |
| 2023Q3 | -60.2 million USD | ? USD |
| 2023Q2 | -64.9 million USD | ? USD |
| 2023Q1 | -42.5 million USD | ? USD |
| 2022Q4 | -37.5 million USD | ? USD |
| 2022Q3 | -40.5 million USD | ? USD |
| 2022Q2 | -51.9 million USD | ? USD |
| 2022Q1 | -35.4 million USD | ? USD |
| 2021Q4 | -51.8 million USD | ? USD |
| 2021Q3 | -42.6 million USD | ? USD |
| 2021Q2 | -30.0 million USD | ? USD |
| 2021Q1 | -25.0 million USD | ? USD |
| 2020Q4 | -28.6 million USD | ? USD |
| 2020Q3 | -13.9 million USD | ? USD |
| 2020Q2 | -9.0 million USD | ? USD |
| 2020Q1 | -7.9 million USD | ? USD |
| 2019Q4 | -5.4 million USD | ? USD |
| 2019Q3 | -5.9 million USD | ? USD |
| 2019Q2 | -3.6 million USD | ? USD |
| 2017Q4 | -1.4 billion USD | 470.0 million USD |
| 2017Q3 | -133.0 million USD | 182.0 million USD |
| 2017Q2 | -296.0 million USD | 181.0 million USD |
| 2017Q1 | 597.0 million USD | 175.0 million USD |
| 2016Q4 | -182.0 million USD | 791.0 million USD |
| 2016Q3 | -249.0 million USD | 241.0 million USD |
| 2016Q2 | -803.0 million USD | 166.0 million USD |
| 2016Q1 | -10.0 million USD | 168.0 million USD |
| 2015Q4 | -134.0 million USD | 217.0 million USD |
| 2015Q3 | -24.0 million USD | 625.0 million USD |
| 2015Q2 | 388.0 million USD | 1.6 billion USD |
| 2015Q1 | -180.0 million USD | 632.0 million USD |
| 2014Q4 | 102.0 million USD | 1.5 billion USD |
| 2014Q3 | -5.0 million USD | 615.0 million USD |
| 2014Q2 | -122.0 million USD | 521.0 million USD |
| 2014Q1 | -37.0 million USD | 762.0 million USD |
| 2013Q4 | -91.0 million USD | 3.0 million USD |
| 2013Q3 | 22.0 million USD | 446.0 million USD |
| 2013Q2 | -145.0 million USD | 301.0 million USD |
| 2013Q1 | -142.0 million USD | 318.0 million USD |
| 2012Q4 | 1.3 billion USD | 312.0 million USD |
| 2012Q3 | -70.0 million USD | 812.0 million USD |
| 2012Q2 | -1.1 billion USD | 198.0 million USD |
| 2012Q1 | -58.0 million USD | 177.0 million USD |
| 2011Q4 | -1.4 billion USD | 238.0 million USD |
| 2011Q3 | -75.0 million USD | 516.0 million USD |
| 2011Q2 | -116.0 million USD | 326.0 million USD |
| 2011Q1 | -77.0 million USD | 505.0 million USD |
| 2010Q4 | -164.0 million USD | 451.0 million USD |
| 2010Q3 | -24.0 million USD | 775.0 million USD |
| 2010Q2 | -191.0 million USD | 239.0 million USD |
| 2010Q1 | 145.0 million USD | 858.0 million USD |
| 2009Q4 | -356.0 million USD | 441.0 million USD |
| 2009Q3 | -223.0 million USD | 630.0 million USD |
| 2009Q2 | -683.0 million USD | 872.0 million USD |
| 2009Q1 | ? USD | 525.0 million USD |
| 2008Q4 | -7.0 million USD | 795.0 million USD |
| 2008Q3 | 605.0 million USD | 1.9 billion USD |
| 2008Q2 | -272.0 million USD | 94.0 million USD |
| 2008Q1 | -152.0 million USD | 774.0 million USD |
| 2007Q4 | -46.0 million USD | 724.0 million USD |
| 2007Q3 | 220.0 million USD | 1.0 billion USD |
| 2007Q2 | 76.0 million USD | 760.0 million USD |
DYN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -235.9 million USD | ? USD |
| 2022 | -165.2 million USD | ? USD |
| 2021 | -149.3 million USD | ? USD |
| 2020 | -58.7 million USD | ? USD |
| 2019 | -13.5 million USD | ? USD |
| 2018 | -4.8 million USD | ? USD |
| 2017 | 76.0 million USD | 506.0 million USD |
| 2016 | -1.2 billion USD | 1.4 billion USD |
| 2015 | 50.0 million USD | 842.0 million USD |
| 2014 | -67.0 million USD | 1.5 billion USD |
| 2013 | -356.0 million USD | 3.0 million USD |
| 2012 | 87.0 million USD | 3.0 million USD |
| 2011 | -1.6 billion USD | 1.6 billion USD |
| 2010 | -234.0 million USD | 2.3 billion USD |
| 2009 | -1.3 billion USD | 2.5 billion USD |
| 2008 | 174.0 million USD | 3.5 billion USD |
| 2007 | 264.0 million USD | 3.1 billion USD |
DYN
Price: $26.08
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.98 USD
P/E Ratio: -6.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 169300
Ebitda: 950.0 millionMarket Capitalization: 2.2 billion
Average Dividend Frequency: 4